share_log

Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com

Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com

股票新闻网站上调了Globus Medical(纽约证券交易所代码：GMED)的股票评级
kopsource ·  2022/08/15 23:11

Globus Medical (NYSE:GMED – Get Rating) was upgraded by equities research analysts at StockNews.com from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Monday.

在周一发布给客户和投资者的一份研究报告中，股票研究分析师将Globus Medical(纽约证券交易所代码：GMED-GET Rating)的评级从持有上调至买入。

A number of other research firms have also recently issued reports on GMED. Piper Sandler cut their price objective on shares of Globus Medical from $80.00 to $75.00 and set an "overweight" rating on the stock in a research report on Friday, August 5th. BTIG Research decreased their price objective on shares of Globus Medical to $71.00 in a research note on Tuesday, August 9th. Morgan Stanley reduced their target price on shares of Globus Medical from $68.00 to $62.00 and set an "equal weight" rating for the company in a research report on Friday, July 15th. Wells Fargo & Company cut their price objective on shares of Globus Medical from $80.00 to $70.00 in a report on Wednesday, May 11th. Finally, Canaccord Genuity Group cut their price objective on shares of Globus Medical from $80.00 to $75.00 in a report on Wednesday, May 11th. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $77.36.

其他一些研究公司最近也发布了关于GMED的报告。派珀·桑德勒在8月5日星期五的一份研究报告中将Globus Medical的股票目标价从80.00美元下调至75.00美元，并对该股设定了“增持”评级。BTIG Research在8月9日星期二的一份研究报告中将Globus Medical的股票目标价下调至71.00美元。摩根士丹利在7月15日(周五)的一份研究报告中将Globus Medical的股票目标价从68.00美元下调至62.00美元，并为该公司设定了“同等权重”的评级。富国银行在5月11日星期三的一份报告中将Globus Medical的股票目标价从80.00美元下调至70.00美元。最后，在5月11日星期三的一份报告中，Canaccel Genuity Group将Globus Medical的股票目标价从80.00美元下调至75.00美元。一名投资分析师对该股的评级为持有，9名分析师对该公司的评级为买入。根据MarketBeat的数据，该股目前的普遍评级为“适度买入”，平均目标价为77.36美元。

Get
到达
Globus Medical
Globus Medical
alerts:
警报：

Globus Medical Price Performance

Globus医疗价格表现

Shares of Globus Medical stock traded up $0.87 during trading on Monday, hitting $67.54. The company's stock had a trading volume of 447,187 shares, compared to its average volume of 704,046. The stock has a market cap of $6.72 billion, a price-to-earnings ratio of 45.33, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The stock has a 50-day moving average price of $58.49 and a two-hundred day moving average price of $65.36. Globus Medical has a 52 week low of $52.60 and a 52 week high of $84.23.

在周一的交易中，Globus Medical的股价上涨了0.87美元，达到67.54美元。该公司股票的成交量为447,187股，而其平均成交量为704,046股。该股市值为67.2亿美元，市盈率为45.33倍，市盈率为3.19倍，贝塔系数为1.13。该股的50日移动均线价格为58.49美元，200日移动均线价格为65.36美元。Globus Medical的52周低点为52.60美元，52周高点为84.23美元。

Institutional Trading of Globus Medical

Globus Medical的制度性交易

A number of hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. lifted its position in Globus Medical by 0.7% during the first quarter. BlackRock Inc. now owns 7,347,858 shares of the medical device company's stock valued at $542,124,000 after purchasing an additional 48,913 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its position in Globus Medical by 125.8% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,562,730 shares of the medical device company's stock valued at $256,152,000 after purchasing an additional 2,542,264 shares during the period. Wellington Management Group LLP increased its position in Globus Medical by 0.6% during the 1st quarter. Wellington Management Group LLP now owns 3,236,599 shares of the medical device company's stock valued at $238,796,000 after purchasing an additional 20,375 shares during the period. State Street Corp increased its position in Globus Medical by 2.9% during the 1st quarter. State Street Corp now owns 2,219,112 shares of the medical device company's stock valued at $163,726,000 after purchasing an additional 62,156 shares during the period. Finally, Champlain Investment Partners LLC grew its position in shares of Globus Medical by 7.6% in the 4th quarter. Champlain Investment Partners LLC now owns 1,757,735 shares of the medical device company's stock worth $126,908,000 after buying an additional 123,500 shares during the last quarter. 67.19% of the stock is owned by hedge funds and other institutional investors.
一些对冲基金和其他机构投资者最近调整了对该公司的持股。今年第一季度，贝莱德将其在Globus Medical的持股比例提高了0.7%。贝莱德股份有限公司在上季度增持了48,913股后，目前持有这家医疗器械公司7,347,858股股票，价值542,124,000美元。凯恩·安德森·鲁德尼克投资管理公司在第二季度将其在Globus Medical的持仓增加了125.8%。Kayne Anderson Rudnick Investment Management LLC在此期间又购买了2,542,264股，现在拥有这家医疗设备公司4,562,730股股票，价值256,152,000美元。惠灵顿管理集团LLP在第一季度将其在Globus Medical的头寸增加了0.6%。惠灵顿管理集团(Wellington Management Group LLP)在此期间额外购买了20,375股惠灵顿医疗器械公司的股票，目前持有该公司3,236,599股股票，价值238,796,000美元。道富集团在第一季度将其在Globus Medical的头寸增加了2.9%。道富集团目前持有这家医疗设备公司2,219,112股票，价值163,726,000美元，在此期间又购买了62,156股票。最后，尚普兰投资伙伴有限责任公司在第四季度将其在Globus Medical的股票头寸增加了7.6%。尚普兰投资伙伴有限责任公司现在拥有这家医疗设备公司1,757,735股票，价值126,908,000美元，在上个季度额外购买了123,500股票。67.19%的股票由对冲基金和其他机构投资者持有。

Globus Medical Company Profile

Globus医疗公司简介

(Get Rating)

(获取评级)

Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.

Globus Medical，Inc.是一家医疗设备公司，为美国和国际上的肌肉骨骼疾病患者开发和销售保健解决方案。它提供脊柱产品，例如用于治疗退变、畸形、肿瘤和创伤条件的传统融合植入物，包括椎弓根螺钉和棒系统、钢板系统、椎间间隔器和椎体切除设备；运动保护技术的治疗选项，包括动态稳定、全椎间盘置换和棘间牵张设备；用于治疗椎体压缩骨折的介入性疼痛管理解决方案；以及由同种异体移植物和合成替代品组成的再生生物产品。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Globus Medical (GMED)
  • The Five Hottest Calls From The Q2 Earnings Season
  • Here is a Simple 4 Stock Portfolio that Can Outperform the Market
  • Is AMC Entertainment Pulling a Fast One on the APEs?
  • Here's How the Inflation Reduction Act Energizes Power Stock
  • The Institutions Trim Holdings Of High-Yielding Foot Locker, Inc
  • 免费获取StockNews.com关于Globus Medical(GMED)的研究报告
  • 第二季度财报季最热门的五个电话
  • 以下是一个简单的4只股票投资组合，它可以跑赢大盘
  • AMC娱乐公司是在对猩猩采取快速行动吗？
  • 以下是《降低通胀法案》如何提振电力库存
  • 机构调整高收益Foot Locker，Inc.的控股

Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Globus医学日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Globus Medical和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发